Good hair-loss advice around hair transplant vs prp vs finasteride has to separate visible change from camera noise, panic, and marketing. The practical value is in staging the pattern, understanding options, and avoiding promises no one can honestly make from a single image.
Last fall, a friend of mine, a 31-year-old attorney named Daniel, texted me a top-down photo of his crown after his barber told him, unprompted, “We might want to talk about how we’re cutting up here.” Daniel had no idea his vertex was thinning. His hairline looked fine to him in the bathroom mirror. He’d never heard of the Norwood scale. Within a week he’d self-diagnosed as a Norwood 5 on Reddit (he wasn’t), purchased a laser cap from Instagram (dubious), and started panicking about surgical costs in Turkey. Almost everything about his approach was backwards.
That sequence is remarkably common. And the corrective to it is boring: understand the classification system, understand the biology, then make decisions in the right order.
The Norwood scale is the standard dermatology classification for male pattern hair loss. Seven main stages, several variant subtypes. O’Tar Norwood formalized it in 1975 as an extension of James Hamilton’s 1951 androgen-and-hair-loss work. It has survived every attempt to replace it, including the basic and specific (BASP) classification proposed in 2007, because it’s simple enough to use consistently across different clinicians while capturing enough real variation to be useful.
This article walks through the same territory a dermatology evaluation would, from classification to biology to treatment evidence to what things actually cost.
Where the Classification Comes From
Hamilton’s 1951 paper in the Annals of the New York Academy of Sciences established the androgen connection. He observed that men castrated before puberty didn’t develop the characteristic recession and crown thinning of androgenetic alopecia. No androgens, no pattern loss. That was the foundation.
Norwood’s 1975 paper in the Southern Medical Journal expanded Hamilton’s three-stage framework into seven stages with variant subtypes, including the Type A variant, where loss marches straight back from the front rather than following the classic bitemporal-plus-vertex pattern. If you’ve ever wondered why someone’s hair loss looks different from the typical “island of hair on top with temples gone” presentation, Type A variants are frequently the answer.
The combined Hamilton-Norwood scale has dominated for over 70 years. It’s not perfect. It compresses a lot of variability into seven bins. But clinicians keep using it because it works as a shared language, which is ultimately what a classification system needs to do.
For a more detailed walkthrough of each stage with photographic references, https://www.myhairline.ai/blog/hair-transplant-vs-prp-vs-finasteride covers the stage-by-stage interpretation well.
DHT, Miniaturization, and Why Your Grandfather Matters (Sort Of)
The biology is straightforward once you get past the terminology. Testosterone converts to dihydrotestosterone (DHT) via the 5-alpha reductase enzyme. DHT is the more potent androgen. In follicles that are genetically susceptible, DHT binds to androgen receptors in the dermal papilla and triggers a slow-motion collapse across successive growth cycles.
What that looks like, mechanistically: the anagen (growth) phase gets shorter. The telogen (resting) phase gets longer. The dermal papilla itself shrinks. Hairs that once grew thick, long, and pigmented become thinner, shorter, and eventually turn into fine vellus hairs that contribute almost nothing to visible coverage. This is follicular miniaturization, and it’s the core process that the Norwood stages are tracking from the outside.
The genetics are polygenic. The androgen receptor gene on the X chromosome is one documented locus, which is where the “look at your mother’s father” advice comes from. But autosomal loci and the paternal side both contribute meaningfully. Family history is a rough signal, not a verdict.
Two drugs exploit this biology directly. Finasteride blocks the type II isoform of 5-alpha reductase, lowering scalp DHT. Dutasteride blocks both type I and type II isoforms, lowering DHT more aggressively. Both have documented effects on hair density in clinical trials.
How Dermatologists Actually Evaluate Hair Loss
The American Academy of Dermatology’s clinical guidelines describe a structured approach that goes well beyond “yeah, you’re thinning up there.”
A complete workup includes patient history (timeline, progression pattern, medications, recent illness, dietary changes), family history, scalp examination, and trichoscopy, which is dermoscopy applied to the scalp. Trichoscopy picks up things the naked eye misses: caliber variability of 20% or more across hair shafts, yellow dots from empty follicular ostia, decreased follicular unit density in affected areas versus preserved density in the occipital donor zone.
Lab testing is selective. Ferritin, TSH, vitamin D, and CBC make sense when telogen effluvium is on the table or the thinning is diffuse. The AAD does not recommend androgen panels routinely in men with classic pattern loss because the diagnosis is clinical. Ordering a full hormone panel on every guy with Norwood 3 temples is expensive screening theater.
Standardized photography (front, top, sides, back, consistent distance and lighting) matters more than most patients think. Without it, you’re relying on memory and mirror angles to track progression over months, which is basically useless.
What the Treatment Evidence Actually Supports
Here’s my genuinely held opinion: most men with early-to-moderate pattern hair loss overthink surgical options and underthink medical ones. The evidence base for medical therapy started early is strong. Surgery is powerful but can’t be the first move for a 27-year-old whose loss pattern hasn’t stabilized.
Oral finasteride 1 mg daily has the largest evidence base. The original five-year randomized trial (JAAD, 2002) showed sustained improvements in hair count versus placebo. Sexual dysfunction, the side effect everyone fixates on, affects a small percentage of users in randomized trials and is generally reversible on discontinuation. That’s not zero risk, but it’s specific, quantified risk, which is the kind you can make decisions about.
Topical minoxidil 5% twice daily is FDA-approved and available over the counter. The mechanism isn’t fully understood but involves potassium channel opening, vasodilation, and a direct follicular effect that prolongs anagen. Results typically become visible at three to six months.
Low-dose oral minoxidil (0.25 to 5 mg daily) is increasingly used off-label following Vañó-Galván et al.’s 2021 multicenter safety study of 1,404 patients, which showed a more manageable side-effect profile at low doses than the original cardiovascular formulation suggested. Periorbital edema and hypertrichosis are reported, but serious adverse events were rare.
Dutasteride is approved for benign prostatic hypertrophy and used off-label for hair loss. Head-to-head trials against finasteride show larger DHT reductions and larger hair density improvements. It’s a reasonable escalation when finasteride alone isn’t enough.
PRP and microneedling have a modest evidence base as adjuncts. JAMA Dermatology has published several smaller randomized trials with positive but variable findings. They’re reasonable additions, not replacements.
Hair transplantation (FUE or FUT) is the only intervention that physically moves follicles from the donor area to the recipient area. It’s most appropriate when the loss pattern is stable, donor capacity is adequate, and expectations are realistic. Doing it too early, before the pattern declares itself, is how you end up with an unnatural result ten years later. Like pouring a concrete patio before you’ve decided where the garden goes.
What Treatment Actually Costs
Generic oral finasteride 1 mg runs $10 to $25 per month at US pharmacies with common discount cards, sometimes as low as $5 to $15 through direct-to-consumer telehealth. Branded Propecia at $70 to $90 monthly has no documented clinical advantage.
Generic topical minoxidil 5% costs $10 to $30 per month. Branded Rogaine roughly doubles that. Foam and solution are clinically equivalent; foam gets a slight preference from patients who report scalp irritation with the propylene glycol in the solution.
Low-dose oral minoxidil in generic form is often under $15 per month. The real cost driver is the prescribing visit ($50 to $150 through telehealth, or covered by insurance through a routine derm appointment).
Hair transplantation in the US runs $4 to $10 per graft for FUE. A typical 2,500 to 3,500 graft case lands at $10,000 to $35,000. In Turkey, similar graft counts go for $2,000 to $5,000, reflecting labor cost and clinic overhead differences rather than necessarily quality differences (though quality variance in medical tourism is real and worth investigating before you book a flight).
PRP costs $500 to $1,500 per session. Most protocols recommend three to four sessions in the first year plus maintenance. The first-year total can equal or exceed a full year of combination medical therapy. That math is worth doing before committing.
Insurance generally classifies pattern hair loss treatment as cosmetic and doesn’t cover it. HSAs and FSAs may cover prescribed medications and physician visits but typically exclude surgical procedures.
Lifestyle Factors: The Short, Honest List
Pattern hair loss is genetically determined. No amount of kale is going to override your androgen receptor sensitivity. But a few lifestyle factors influence the rate, and the peer-reviewed literature (primarily in JAAD and the International Journal of Trichology) is clear on which ones.
Smoking accelerates loss through microvascular damage, oxidative stress, and androgen effects. Cross-sectional studies show higher rates of androgenetic alopecia in smokers versus matched nonsmokers.
Iron deficiency (serum ferritin below 30 ng/mL in women, below 50 ng/mL when hair loss is a concern) contributes to shedding through telogen effluvium. Iron repletion helps. Iron supplementation in iron-replete patients does nothing for hair density.
Severe acute stress can trigger telogen effluvium two to three months after the precipitating event, typically resolving within six to nine months once the stressor passes, though it may unmask underlying pattern loss that was previously subclinical.
Anabolic steroid use accelerates pattern hair loss in genetically susceptible men through supraphysiologic androgen exposure, with effects that may not be fully reversible after discontinuation. This is worth saying clearly because the men most likely to use them are also in the age range where pattern loss first becomes visible.
Severe caloric restriction, very low protein intake, and rapid weight loss all reliably produce telogen effluvium. Modest dietary improvements beyond addressing specific deficiencies don’t produce visible hair benefits.
When to Skip Telehealth and See a Dermatologist in Person
Self-management is reasonable in a lot of cases. But certain presentations need hands-on evaluation.
Sudden, diffuse shedding over the last six months points to telogen effluvium, which needs a precipitant evaluation and selective labs, not finasteride.
Patchy loss with smooth, well-circumscribed bald patches suggests alopecia areata (autoimmune, entirely different treatment pathway).
Scalp pain, burning, redness, scaling, or visible scarring raises concern for scarring alopecias (lichen planopilaris, frontal fibrosing alopecia, central centrifugal cicatricial alopecia), which require prompt diagnosis to prevent permanent follicle destruction.
Rapid progression in a young patient (more than one Norwood stage per year) warrants in-person confirmation and early intervention planning.
The AAD’s position, which I think is right, is that any progressive hair loss concerning to the patient is a legitimate reason for dermatology consultation. You don’t need to be a Norwood 5 to deserve an evaluation.
FAQs
Is hair loss covered by insurance?
Pattern hair loss treatment is generally classified as cosmetic and not covered. Some HSA and FSA accounts will cover prescribed medications and physician visits.
Do biotin and collagen supplements help with hair loss?
The evidence for biotin or collagen supplementation in patients without documented deficiency is weak. Worth noting: biotin can interfere with several common lab tests, including thyroid function and troponin assays, which can cause diagnostic confusion.
Can pattern hair loss be reversed?
Partially, in some patients, with early treatment. Combination finasteride and minoxidil started before substantial follicular dropout offers the best chance. Late-stage loss with extensive miniaturization is generally not reversible with medical therapy alone.
What is shock loss after a hair transplant?
Temporary shedding of native or transplanted hairs in the weeks following surgery, typically resolving over three to six months as follicles re-enter anagen. It’s alarming but expected.
Should I get a hair transplant if I am in my 20s?
Experienced surgeons approach this cautiously because the long-term progression pattern isn’t established yet. Medical therapy to stabilize native hair is usually the priority first.
How accurate are AI hair-loss assessment tools?
They provide reasonable orientation for self-screening but don’t replace dermatologic evaluation. Best used as a starting point for understanding likely stage and treatment options, not as a diagnosis.
Does wearing hats cause hair loss?
No. This is one of the most persistent myths. Standard hat-wearing does not cause or accelerate androgenetic alopecia.
References
- Hamilton JB. Patterned loss of hair in man: types and incidence. Ann N Y Acad Sci. 1951;53(3):708-728.
- Norwood OT. Male pattern baldness: classification and incidence. South Med J. 1975;68(11):1359-1365.
- Kanti V, Messenger A, Dobos G, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men: short version. J Eur Acad Dermatol Venereol. 2018;32(1):11-22.
- American Academy of Dermatology Association. Hair loss: diagnosis and treatment. AAD clinical guidance.
- Olsen EA, Hordinsky M, Whiting D, et al. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss. J Am Acad Dermatol. 2006;55(6):1014-1023.
- Sinclair RD. Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone. Int J Dermatol. 2018;57(1):104-109.
- Vañó-Galván S, Pirmez R, Hermosa-Gelbard A, et al. Safety of low-dose oral minoxidil for hair loss: a multicenter study of 1404 patients. J Am Acad Dermatol. 2021;84(6):1644-1651.
- Gentile P, Garcovich S. Systematic review of platelet-rich plasma use in androgenetic alopecia compared with minoxidil, finasteride, and adult stem cell-based therapy. Int J Mol Sci. 2020;21(8):2702.
- Kassira S, Korta DZ, Chapman LW, Dann F. Frontal fibrosing alopecia: a review. J Am Acad Dermatol. 2017;77(2):209-212.
- Suchonwanit P, Thammarucha S, Leerunyakul K. Minoxidil and its use in hair disorders: a review. Drug Des Devel Ther. 2019;13:2777-2786.
Educational content, not medical advice. This article summarizes peer-reviewed sources and clinical guidelines for general informational purposes and does not constitute medical advice, diagnosis, or treatment. Hair loss has multiple possible causes, and an in-person dermatology evaluation is the appropriate starting point for any individual case. Do not start, stop, or change medications based on this article.
Privacy framing for AI-based assessment tools: AI hair-loss screening tools such as Myhairline.ai analyze user-submitted photos using MediaPipe Face Mesh 468-landmark detection. Photos are not stored, and no account is required. The AI output is educational, not diagnostic.
